Lipocine (LPCN) Change in Accured Expenses (2011 - 2025)
Lipocine (LPCN) posted Change in Accured Expenses of $63,888 for Q3 2025, up 8.6% from $58,808 a year earlier but down 3.7% from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) Change in Accured Expenses (2011 - 2025) Analysis & Trends
For the trailing twelve months through Sep 30, 2025, Change in Accured Expenses at Lipocine was -$542,618; for FY2024, it was -$297,246.
- In prior years, Lipocine's Change in Accured Expenses was $140,748 in FY2023 (+129.7%), $61,280 in FY2022, -$636,720 in FY2021 and $1.21 million in FY2020.
- Quarterly Change in Accured Expenses has run from a low of -$554,554 in Q4 2021 to a high of $472,012 in Q2 2024 over five years.
- On a year-over-year basis, Change in Accured Expenses increased in two of the last four quarters, with growth averaging 7.7%.
- According to Business Quant data, Change in Accured Expenses for the three prior quarters was $66,369 (Q2 2025), -$301,830 (Q1 2025) and -$371,045 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Lipocine | 11.11 Mn | -56.60 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 63,888.00 |
| Jun 30, 2025 | 66,369.00 |
| Mar 31, 2025 | -301,830.00 |
| Dec 31, 2024 | -371,045.00 |
| Sep 30, 2024 | 58,808.00 |
| Jun 30, 2024 | 472,012.00 |
| Mar 31, 2024 | -457,021.00 |
| Dec 31, 2023 | 78,173.00 |
| Sep 30, 2023 | -169,282.00 |
| Jun 30, 2023 | 175,969.00 |
| Mar 31, 2023 | 55,888.00 |
| Dec 31, 2022 | 196,888.00 |
| Sep 30, 2022 | -18,451.00 |
| Jun 30, 2022 | 331,400.00 |
| Mar 31, 2022 | -448,557.00 |
| Dec 31, 2021 | -554,554.00 |
| Sep 30, 2021 | 126,824.00 |
| Jun 30, 2021 | -60,719.00 |
| Mar 31, 2021 | -148,271.00 |
| Dec 31, 2020 | 119,948.00 |
API Access
Lipocine Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();